Lupin launches biosimilar Ranibizumab in European market
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial growth…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.